OA08462A - Composés hétérocycliques condensés azotés, procédés pour les séparer et composition pharmaceutique en contenant. - Google Patents
Composés hétérocycliques condensés azotés, procédés pour les séparer et composition pharmaceutique en contenant.Info
- Publication number
- OA08462A OA08462A OA59044A OA59044A OA08462A OA 08462 A OA08462 A OA 08462A OA 59044 A OA59044 A OA 59044A OA 59044 A OA59044 A OA 59044A OA 08462 A OA08462 A OA 08462A
- Authority
- OA
- OAPI
- Prior art keywords
- separation
- processes
- pharmaceutical composition
- composition containing
- heterocyclic compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Indole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868601160A GB8601160D0 (en) | 1986-01-17 | 1986-01-17 | Heterocyclic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA08462A true OA08462A (fr) | 1988-07-29 |
Family
ID=10591560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA59044A OA08462A (fr) | 1986-01-17 | 1987-01-16 | Composés hétérocycliques condensés azotés, procédés pour les séparer et composition pharmaceutique en contenant. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4797399A (fr) |
| EP (1) | EP0232740A1 (fr) |
| JP (1) | JPS62181253A (fr) |
| KR (1) | KR870007163A (fr) |
| CN (1) | CN87100707A (fr) |
| AU (1) | AU6762687A (fr) |
| DK (1) | DK8687A (fr) |
| FI (1) | FI865369A (fr) |
| GB (1) | GB8601160D0 (fr) |
| IL (1) | IL81172A0 (fr) |
| NO (1) | NO870053L (fr) |
| OA (1) | OA08462A (fr) |
| PT (1) | PT84103A (fr) |
| ZA (1) | ZA869748B (fr) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2601366B1 (fr) * | 1986-07-10 | 1988-11-25 | Andre Buzas | Derives de la benzhydryloxyethyl-piperazine, procedes d'obtention et de compositions pharmaceutiques les contenant. |
| FI95572C (fi) | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
| GB8714596D0 (en) * | 1987-06-22 | 1987-07-29 | Fujisawa Pharmaceutical Co | Thiazolopyridine compounds |
| FR2663929A1 (fr) * | 1990-06-29 | 1992-01-03 | Adir | Nouveaux derives d'oxazolo pyridines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| FR2669336B1 (fr) * | 1990-11-20 | 1993-01-22 | Adir | Nouveaux derives d'oxazolo pyridines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
| IT1251144B (it) * | 1991-07-30 | 1995-05-04 | Boehringer Ingelheim Italia | Derivati del benzimidazolone |
| IL115420A0 (en) | 1994-09-26 | 1995-12-31 | Zeneca Ltd | Aminoheterocyclic derivatives |
| US6313127B1 (en) | 1996-02-02 | 2001-11-06 | Zeneca Limited | Heterocyclic compounds useful as pharmaceutical agents |
| GB9602294D0 (en) * | 1996-02-05 | 1996-04-03 | Zeneca Ltd | Heterocyclic compounds |
| DE19618999A1 (de) * | 1996-05-10 | 1997-11-13 | Klinge Co Chem Pharm Fab | Neue Benzothiazolinone |
| DE19618970A1 (de) * | 1996-05-10 | 1997-11-13 | Klinge Co Chem Pharm Fab | Neue Thiazolopyridine |
| CZ45699A3 (cs) * | 1996-08-14 | 1999-05-12 | Zeneca Limited | Substituované deriváty pyrimidinu, způsob jejich přípravy a farmaceutický prostředek, který je obsahuje |
| UA56197C2 (uk) | 1996-11-08 | 2003-05-15 | Зенека Лімітед | Гетероциклічні похідні |
| US6440972B1 (en) | 1997-02-13 | 2002-08-27 | Zeneca Limited | Heterocyclic compounds useful as oxido-squalene cyclase inhibitors |
| DE69815509T2 (de) | 1997-02-13 | 2004-05-13 | Astrazeneca Ab | Heterozyklische verbindungen die als oxido-squalen-zyklase-inhibitoren anwendung finden |
| WO1999001454A1 (fr) | 1997-07-03 | 1999-01-14 | Du Pont Pharmaceuticals Company | Imidazopyrimidines et imidazopyridines utiles pour traiter des troubles neurologiques |
| GB9715895D0 (en) | 1997-07-29 | 1997-10-01 | Zeneca Ltd | Heterocyclic compounds |
| US6355800B1 (en) * | 1997-10-09 | 2002-03-12 | Fujisawa Pharmaceutical Co., Ltd. | Process for producing aminopiperazine derivatives |
| US6124463A (en) * | 1998-07-02 | 2000-09-26 | Dupont Pharmaceuticals | Benzimidazoles as corticotropin release factor antagonists |
| US6365589B1 (en) | 1998-07-02 | 2002-04-02 | Bristol-Myers Squibb Pharma Company | Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists |
| GB9902989D0 (en) | 1999-02-11 | 1999-03-31 | Zeneca Ltd | Heterocyclic derivatives |
| CA2415815A1 (fr) * | 2000-07-06 | 2002-01-17 | Nigel H. Greig | Agents neuroprotecteurs a base d'analogues de tetrahydrobenzothiazole |
| US7183410B2 (en) * | 2001-08-02 | 2007-02-27 | Bidachem S.P.A. | Stable polymorph of flibanserin |
| US20030060475A1 (en) * | 2001-08-10 | 2003-03-27 | Boehringer Ingelheim Pharma Kg | Method of using flibanserin for neuroprotection |
| US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
| UA78974C2 (en) | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
| TW200508197A (en) * | 2003-03-31 | 2005-03-01 | Ucb Sa | Indolone-acetamide derivatives, processes for preparing them and their uses |
| AU2005214258A1 (en) * | 2004-02-23 | 2005-09-01 | Dainippon Sumitomo Pharma Co., Ltd. | Novel heterocyclic compound |
| US20050239798A1 (en) * | 2004-04-22 | 2005-10-27 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for the treatment of premenstrual and other female sexual disorders |
| BRPI0510074A (pt) * | 2004-04-22 | 2007-10-16 | Boehringer Ingelheim Int | composições farmacêuticas para o tratamento de distúrbios sexuais ii |
| US20060025420A1 (en) * | 2004-07-30 | 2006-02-02 | Boehringer Ingelheimn International GmbH | Pharmaceutical compositions for the treatment of female sexual disorders |
| WO2006024471A1 (fr) * | 2004-09-03 | 2006-03-09 | Boehringer Ingelheim International Gmbh | Methode de traitement du trouble de l'hyperactivite avec deficit de l'attention |
| CA2599721A1 (fr) * | 2005-03-04 | 2006-09-14 | Boehringer Ingelheim International Gmbh | Compositions pharmaceutiques utiles dans le traitement et/ou la prevention de la depression |
| WO2006096434A2 (fr) * | 2005-03-04 | 2006-09-14 | Boehringer Ingelheim International Gmbh | Compositions pharmaceutiques permettant de traiter et/ou de prevenir les troubles de l'anxiete |
| WO2006096439A2 (fr) * | 2005-03-04 | 2006-09-14 | Boehringer Ingelheim International Gmbh | Compositions pharmaceutiques destinees au traitement et/ou a la prevention de la schizophrenie et de maladies associees |
| WO2006119884A2 (fr) * | 2005-05-06 | 2006-11-16 | Boehringer Ingelheim International Gmbh | Methode de traitement de la toxicomanie |
| EP1888070A1 (fr) * | 2005-05-19 | 2008-02-20 | Boehringer Ingelheim International GmbH | Procede pour le traitement de dysfonctionnements sexuels dus a des etats pathologiques |
| JP2008540673A (ja) * | 2005-05-19 | 2008-11-20 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 薬剤誘発性性機能不全の治療方法 |
| ES2646326T3 (es) | 2005-08-03 | 2017-12-13 | Sprout Pharmaceuticals, Inc. | Uso de flibanserina en el tratamiento de la obesidad |
| US20070123540A1 (en) * | 2005-10-29 | 2007-05-31 | Angelo Ceci | Sexual desire enhancing medicaments comprising benzimidazolone derivatives |
| CA2626134C (fr) * | 2005-10-29 | 2013-12-24 | Boehringer Ingelheim International Gmbh | Derives de benzimidazolone utiles pour le traitement des troubles premenstruels et d'autres troubles sexuels chez la femme |
| US20070105869A1 (en) * | 2005-11-08 | 2007-05-10 | Stephane Pollentier | Use of flibanserin for the treatment of pre-menopausal sexual desire disorders |
| JP2009536176A (ja) * | 2006-05-09 | 2009-10-08 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 閉経後の性的欲求障害の治療のためのフリバンセリンの使用 |
| DE602007004615D1 (de) | 2006-06-30 | 2010-03-18 | Boehringer Ingelheim Pharma | Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen |
| WO2008006838A1 (fr) * | 2006-07-14 | 2008-01-17 | Boehringer Ingelheim International Gmbh | Utilisation de flibansérine pour le traitement de troubles sexuels chez les femmes |
| AR062320A1 (es) * | 2006-08-14 | 2008-10-29 | Boehringer Ingelheim Int | Formulaciones de flibanserina y metodo para fabricarlas |
| CL2007002214A1 (es) * | 2006-08-14 | 2008-03-07 | Boehringer Ingelheim Int | Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp |
| EA200900270A1 (ru) * | 2006-08-25 | 2009-08-28 | Бёрингер Ингельхайм Интернациональ Гмбх | Системы регулируемого высвобождения и способ их приготовления |
| US8686008B2 (en) * | 2007-08-16 | 2014-04-01 | The University Of Mississippi | Highly selective sigma receptor ligands |
| CL2008002693A1 (es) | 2007-09-12 | 2009-10-16 | Boehringer Ingelheim Int | Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA928296A (en) * | 1967-06-05 | 1973-06-12 | Umio Suminori | N-substituted and n, n-disubstituted aminocarbonylalkyl compounds and their production |
| GB1270841A (en) * | 1969-03-28 | 1972-04-19 | Fujisawa Pharmaceutical Co | Benzothiazoline derivatives |
| GR65270B (en) * | 1978-10-10 | 1980-07-31 | Fujisawa Pharmaceutical Co | Isatin derivatives and processes for the preparation thereof |
| US4279909A (en) * | 1980-02-13 | 1981-07-21 | Fujisawa Pharmaceutical Co., Ltd. | Antiallergic method |
| JPS6015276A (ja) * | 1983-07-04 | 1985-01-25 | Nissan Motor Co Ltd | 自動車組立工程における組付部品の仕様判別方法 |
| JPS6063972A (ja) * | 1983-09-17 | 1985-04-12 | Sumitomo Electric Ind Ltd | クライオスタツト |
-
1986
- 1986-01-17 GB GB868601160A patent/GB8601160D0/en active Pending
- 1986-12-23 US US06/945,853 patent/US4797399A/en not_active Expired - Fee Related
- 1986-12-29 ZA ZA869748A patent/ZA869748B/xx unknown
- 1986-12-31 FI FI865369A patent/FI865369A/fi not_active Application Discontinuation
-
1987
- 1987-01-05 IL IL81172A patent/IL81172A0/xx unknown
- 1987-01-06 NO NO870053A patent/NO870053L/no unknown
- 1987-01-08 DK DK008687A patent/DK8687A/da unknown
- 1987-01-14 PT PT84103A patent/PT84103A/pt unknown
- 1987-01-15 EP EP87100448A patent/EP0232740A1/fr not_active Withdrawn
- 1987-01-16 AU AU67626/87A patent/AU6762687A/en not_active Abandoned
- 1987-01-16 OA OA59044A patent/OA08462A/fr unknown
- 1987-01-16 JP JP62008379A patent/JPS62181253A/ja active Pending
- 1987-01-17 CN CN198787100707A patent/CN87100707A/zh active Pending
- 1987-01-17 KR KR870000328A patent/KR870007163A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| FI865369A (fi) | 1987-07-18 |
| CN87100707A (zh) | 1987-09-02 |
| PT84103A (en) | 1987-02-01 |
| EP0232740A1 (fr) | 1987-08-19 |
| NO870053L (no) | 1987-07-20 |
| IL81172A0 (en) | 1987-08-31 |
| ZA869748B (en) | 1987-08-26 |
| DK8687D0 (da) | 1987-01-08 |
| US4797399A (en) | 1989-01-10 |
| NO870053D0 (no) | 1987-01-06 |
| DK8687A (da) | 1987-07-18 |
| KR870007163A (ko) | 1987-08-17 |
| JPS62181253A (ja) | 1987-08-08 |
| GB8601160D0 (en) | 1986-02-19 |
| AU6762687A (en) | 1987-07-23 |
| FI865369A0 (fi) | 1986-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| OA08462A (fr) | Composés hétérocycliques condensés azotés, procédés pour les séparer et composition pharmaceutique en contenant. | |
| OA08647A (fr) | Dérivés d'imidazole, procédés pour leur préparation et composition pharmaceutique les contenant. | |
| OA07103A (fr) | Nouvelles 1,2-diaminocyclobutène-3,4-diones, leur procédé de préparation et composition pharmaceutique les contenant. | |
| FR2567131B1 (fr) | Nouveaux derives de ganglioside, procede pour leur obtention et composition pharmaceutique les contenant | |
| FR2518095B1 (fr) | Nouveaux l-oxa-, thia- et aza-spirocyclo-benzene-acetamides et benzamides, leur procede de preparation et composition pharmaceutique les contenant | |
| BE896724A (fr) | Procede de traitement thermique d'une fraction de plasma, produit obtenu et composition pharmaceutique le contenant. | |
| FR2569402B1 (fr) | Derives d'acide 3,5-pyridine-dicarboxylique, procede pour leur preparation et composition pharmaceutique les contenant | |
| FR2495154B1 (fr) | 5'-aminoalkyl-4', 4, 8-trialkylpsoralenes, leur procede de production et composition pharmaceutique les contenant | |
| OA09441A (fr) | "Procédés de préparation de ptéridin-4(3H)-ones, et de compositions médicamenteuses les contenant". | |
| MC1915A1 (fr) | Procédés pour la préparation de 2',3'-didésoxynucléosides et de formulations pharmaceutiques en contenant | |
| OA07172A (fr) | Nouvelles thiazolidinediones, leur procédé de production et préparation pharmaceutique les contenant. | |
| BE861964A (fr) | Derives de la 1,4-dihydropyridine, leur procede d'obtention et composition pharmaceutique les contenant | |
| FR2490493B1 (fr) | Composition pharmaceutique ou alimentaire contenant de l'a -cetoglutarate de pyridoxine, procede pour sa preparation | |
| FI851369A0 (fi) | Anordning foer rening av vatten, speciellt avfallsvatten medelst ett biologiskt oxidationsfoerfarande. | |
| FR2569702B1 (fr) | Nouvelle 4'-deschlororebeccamycine, composition pharmaceutique la contenant et procede pour sa preparation | |
| BE892552A (fr) | Nouveaux amido-aminoacides, compositions pharmaceutiques les contenant et procede de preparation de ces amido-aminoacides | |
| OA07585A (fr) | Nouveaux composés hétérocycliques, leur procédé de préparation et composition pharmaceutique les contenant. | |
| OA09749A (fr) | "1-aryl-5-(alkylidèneimino substitué)-pyrazoles pesticides, procédés pour leur préparation, compositions les contenant et leur utilisation". | |
| OA07341A (fr) | Nouveaux oximéthers, procédé pour leur préparation, agents contenant les nouveaux oximéthers et leur application. | |
| FR2594847B1 (fr) | Procede de preparation de polypeptides biologiquement actifs, polypeptides obtenus et compositions les contenant | |
| FR2600061B1 (fr) | Derives d'indole, composition pharmaceutique les contenant et procede pour leur preparation | |
| FR2528425B1 (fr) | 1,4-dihydropyridines et composition pharmaceutique les contenant | |
| FR2601951B1 (fr) | Nouvelles tetrahydrocarbazolones, composition pharmaceutique les contenant et leur procede de preparation | |
| OA07171A (fr) | Spirothiazolidineone, son procédé de préparation et préparation pharmaceutique la contenant. | |
| MC1549A1 (fr) | Anthracycline-glycosides,procede pour leur preparation et medicaments les contenant |